top of page

BOOSTRIX POLIO SUSPENSION FOR INJECTION

Product details

Registration number: SIN15888P

Classification: Prescription Only

Active ingredients:

  • Diphtheria toxoid
  • Filamentous Hemagglutinin (FHA)
  • Inactivated polio virus type 1
  • Inactivated polio virus type 2
  • Inactivated polio virus type 3
  • Pertactin (PRN)
  • Pertussis toxoid (PT)
  • Tetanus toxoid

Strength:

  • 2.5 Lf/ 0.5 ml - not less than 2 IU
  • 8 mcg/0.5ml
  • 40 DU/0.5 ml
  • 8 DU/0.5 ml
  • 32 DU/0.5 ml
  • 2.5 mcg/0.5 ml
  • 8 mcg/0.5 ml
  • 5.0 Lf/0.5ml - not less than 20 IU

Dosage form: INJECTION, SUSPENSION

Route: INTRAMUSCULAR

Registrant: GLAXOSMITHKLINE PTE LTD

ATC code: J07CA02

HSA approval date: 20 February 2020

Manufacturer(s): GlaxoSmithKline Biologicals SAS

Manufacturing country/countries: FRANCE

What are the HSA registration number and classification for BOOSTRIX POLIO SUSPENSION FOR INJECTION?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN15888P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for BOOSTRIX POLIO SUSPENSION FOR INJECTION?

According to the HSA dataset updated 7 August 2026:

Active ingredients:

  • Diphtheria toxoid
  • Filamentous Hemagglutinin (FHA)
  • Inactivated polio virus type 1
  • Inactivated polio virus type 2
  • Inactivated polio virus type 3
  • Pertactin (PRN)
  • Pertussis toxoid (PT)
  • Tetanus toxoid

Strength:

  • 2.5 Lf/ 0.5 ml - not less than 2 IU
  • 8 mcg/0.5ml
  • 40 DU/0.5 ml
  • 8 DU/0.5 ml
  • 32 DU/0.5 ml
  • 2.5 mcg/0.5 ml
  • 8 mcg/0.5 ml
  • 5.0 Lf/0.5ml - not less than 20 IU

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for BOOSTRIX POLIO SUSPENSION FOR INJECTION?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, SUSPENSION

Route: INTRAMUSCULAR

Source for this answer

Who is the recorded registrant for BOOSTRIX POLIO SUSPENSION FOR INJECTION?

According to the HSA dataset updated 7 August 2026:

Registrant: GLAXOSMITHKLINE PTE LTD

Source for this answer

Which manufacturers and countries are listed for BOOSTRIX POLIO SUSPENSION FOR INJECTION?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): GlaxoSmithKline Biologicals SAS

Manufacturing country/countries: FRANCE

Source for this answer

Where can I look up BOOSTRIX POLIO SUSPENSION FOR INJECTION in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN15888P or the exact product name BOOSTRIX POLIO SUSPENSION FOR INJECTION. The general register link does not preselect this product.

Source for this answer

What are the source dates for this BOOSTRIX POLIO SUSPENSION FOR INJECTION record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this BOOSTRIX POLIO SUSPENSION FOR INJECTION record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN15888P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page